These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20707772)

  • 21. Advances in Research on Contingency Management for Adolescent Substance Use.
    Stanger C; Lansing AH; Budney AJ
    Child Adolesc Psychiatr Clin N Am; 2016 Oct; 25(4):645-59. PubMed ID: 27613343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contingency contracting with drug abusers in the natural environment.
    Boudin HM; Valentine VE; Inghram RD; Brantley JM; Ruiz MR; Smith GG; Catlin RP; Regan EJ
    Int J Addict; 1977 Feb; 12(1):1-16. PubMed ID: 863555
    [No Abstract]   [Full Text] [Related]  

  • 23. Social functioning outcomes among individuals with substance use disorders receiving internet-delivered community reinforcement approach.
    Marino LA; Campbell ANC; Pavlicova M; Hu M; Nunes EV
    Subst Use Misuse; 2019; 54(7):1067-1074. PubMed ID: 30849925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A contingency analysis of family treatment and drug abuse.
    Todd TC
    NIDA Res Monogr; 1984; 46():104-14. PubMed ID: 6427618
    [No Abstract]   [Full Text] [Related]  

  • 25. Closing the research-to-implementation gap for contingency management as an effective intervention for substance use disorders across diverse communities.
    Hirchak K
    Addiction; 2024 Sep; 119(9):1519-1521. PubMed ID: 38770791
    [No Abstract]   [Full Text] [Related]  

  • 26. Virtual contingency management, what is it worth and who will pay for it?
    McKetin R; Clay S
    Addiction; 2024 Sep; 119(9):1517-1518. PubMed ID: 38752258
    [No Abstract]   [Full Text] [Related]  

  • 27. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.
    Mitchell SG; Monico LB; Stitzer M; Matheson T; Sorensen JL; Feaster DJ; Schwartz RP; Metsch L
    J Subst Abuse Treat; 2018 Nov; 94():18-23. PubMed ID: 30243412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence.
    Ninnemann AL; Lechner WV; Borges A; Lejuez CW
    Addict Behav; 2016 Dec; 63():72-3. PubMed ID: 27424166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of reinforcement-based interventions for substance use: Efficacy, mechanisms of action, and moderators of treatment effects.
    Fazzino TL; Bjorlie K; Lejuez CW
    J Subst Abuse Treat; 2019 Sep; 104():83-96. PubMed ID: 31370989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral therapies for substance abuse.
    Childress AR; McLellan AT; O'Brien CP
    Int J Addict; 1985; 20(6-7):947-69. PubMed ID: 2867051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinician-delivered contingency management increases engagement and attendance in drug and alcohol treatment.
    Fitzsimons H; Tuten M; Borsuk C; Lookatch S; Hanks L
    Drug Alcohol Depend; 2015 Jul; 152():62-7. PubMed ID: 25982007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contingency management for treatment of substance use disorders: a meta-analysis.
    Prendergast M; Podus D; Finney J; Greenwell L; Roll J
    Addiction; 2006 Nov; 101(11):1546-60. PubMed ID: 17034434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contingency management approaches to drug self-administration and drug abuse: efficacy and limitations.
    Bigelow GE; Stitzer ML; Griffiths RR; Liebson IA
    Addict Behav; 1981; 6(3):241-52. PubMed ID: 7293847
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroscience of behavioral and pharmacological treatments for addictions.
    Potenza MN; Sofuoglu M; Carroll KM; Rounsaville BJ
    Neuron; 2011 Feb; 69(4):695-712. PubMed ID: 21338880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion of contingency management and attitudes regarding its effectiveness and acceptability.
    Bride BE; Abraham AJ; Roman PM
    Subst Abus; 2010 Jul; 31(3):127-35. PubMed ID: 20687001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analytic review of psychosocial interventions for substance use disorders.
    Dutra L; Stathopoulou G; Basden SL; Leyro TM; Powers MB; Otto MW
    Am J Psychiatry; 2008 Feb; 165(2):179-87. PubMed ID: 18198270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effectiveness of Ultra-Low Magnitude Reinforcers: Findings From a "Real-World" Application of Contingency Management.
    Kropp F; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 Jan; 72():111-116. PubMed ID: 27422452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First Evaluation of a Contingency Management Intervention Addressing Adolescent Substance Use and Sexual Risk Behaviors: Risk Reduction Therapy for Adolescents.
    Letourneau EJ; McCart MR; Sheidow AJ; Mauro PM
    J Subst Abuse Treat; 2017 Jan; 72():56-65. PubMed ID: 27629581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis.
    Getty CA; Morande A; Lynskey M; Weaver T; Metrebian N
    Addiction; 2019 Nov; 114(11):1915-1925. PubMed ID: 31265747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
    Roll JM
    Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.